Gallo, R. C. (2005). The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology, 2, 17. http://doi.org/10.1186/1742-4690-2-17
Gallo RC. A Reflection on HIV/AIDS Research after 25 Years. Retrovirology, 3:72, 2006.
Gallo, RC. HIV: dark and light, then & now. Future Virology1(1): (2006) 1-3
GALLO, R.C., 1985. The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future. Cancer research, 45(9 Suppl), pp. 4533s.
Dr. Gallo has been awarded 30 honorary doctorates from universities in the United States, Sweden, Italy, Israel, Peru, Germany, Belgium, Mexico, Argentina, Spain, Ireland, Jamaica and Greece. He is a member of numerous professional and honorary societies including the U.S. National Academy of Sciences, the Institute of Medicine of the U.S. National Academy of Sciences, the Royal Society of Medicine (Glasgow, Scotland), the Royal Society of Medicine (Brussels, Belgium), the Royal College of Physicians (Ireland) 2007, among several others, and a member of the National Inventors Hall of Fame.
He has received numerous major scientific honors and awards. What follows is a partial list:
Dr. Gallo was the most cited scientist in the world 1980-1990, according to the Institute for Scientific Information (Science July 27, 1990, p. 358), and he was ranked third in the world for scientific impact for the period 1983-2002 (PNAS, November 15, 2005, vol102, no.46, 6569-16572). He has published close to 1,200 papers.
NOTICE OF NONDISCRIMINATORY POLICY AS TO STUDENTS
The New York Medical College admits students of any race, color, national and ethnic origin to all the rights, privileges, programs, and activities generally accorded or made available to students at the college. It does not discriminate on the basis of race, color, national and ethnic origin in administration of its educational policies, admissions policies, scholarship and loan programs, and athletic and other school-administered programs. See full non-discrimination statement with contact info.